Market Indices
Latest News
 |
Kezar Life Sciences, Inc. (KZR) confirmed earnings release on March 31,...
March 30, 2026 KZR 19.27% |
| ||
| ||
| ||
|
Price Targets
Roger Song from Jefferies issued a price target of $16.00 for CTMX on 2026-03-18 14:16:00.The adjusted price target was set to $16.00.At the time of the announcement, CTMX...
March 18, 2026 CTMX -5.09%
Stephen Willey from Stifel Nicolaus issued a price target of $17.00 for ABEO on 2026-03-17 19:53:00.The adjusted price target was set to $17.00.At the time of the announcement,
March 17, 2026 ABEO 0.58%
Michael Baker from D.A. Davidson issued a price target of $68.00 for CTRN on 2026-03-17 19:35:00.The adjusted price target was set to $68.00.At the time of the announcement,
March 17, 2026 CTRN -0.30%
Aaron Spychalla from Craig-Hallum issued a price target of $19.00 for BW on 2026-03-17 13:54:00.The adjusted price target was set to $19.00.At the time of the announcement, BW...
March 17, 2026 BW -11.41%
Greg Renza from Truist Financial issued a price target of $12.00 for CATX on 2026-03-17 12:35:00.The adjusted price target was set to $12.00.At the time of the announcement,
March 17, 2026 CATX -5.16%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| ARBEW Arbe Robotics Ltd. Warran | 0.08
59.63% | ||||||||||||||||||
| SLND Southland Holdings, Inc. | 1.58
29.10% | ||||||||||||||||||
| CMCT Creative Media & Communit | 0.72
27.74% | ||||||||||||||||||
| IONR ioneer Ltd | 4.41
23.18% | ||||||||||||||||||
| KZR Kezar Life Sciences, Inc. | 7.40
19.27% | ||||||||||||||||||
| NKGN NKGen Biotech, Inc. Commo | 0.07
16.67% | ||||||||||||||||||
| BZUN Baozun Inc. | 2.34
11.46% | ||||||||||||||||||
| GEVO Gevo, Inc. | 2.79
10.87% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -9.11%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -7.34%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -3.20%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 0.56%